Skip to content

A randomised controlled trial to assess the effectiveness of the Breaking Free from Smoking online intervention for offenders in UK prisons

A randomised controlled trial to assess the effectiveness of the Breaking Free from Smoking online intervention for offenders in UK prisons

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN39840514
Enrollment
128
Registered
2018-02-12
Start date
2018-06-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco

Interventions

Participants will be assigned to one of the study groups following the generation of a random allocation sequence via the Research Randomizer (from the Social Psychology Network- Urbaniak and Plous, 2

Sponsors

Breaking Free Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and over 2. Currently smoking tobacco 3. Attending the standard stop smoking programme 4. Willing to make a quit attempt in the next 14 days 5. Willing to complete the assessment measures 6. Willing to complete an online programme 7. Able to read and understand materials written in the English language 8. Not scheduled for release within 12 weeks of enrolment to the study

Exclusion criteria

Exclusion criteria: 1. Aged 17 or under 2. Not smoking tobacco at the attendance to the first stop smoking session of the standard prison smoking cessation support 3. Not willing to make a quit attempt in the next 14 days 4. Not willing to complete the assessment measures 5. Not willing to complete an online programme 6. Unable to read and understand materials written in the English language 7. Release or transfer pending within the next 12 weeks

Design outcomes

Primary

MeasureTime frame
Self-reported smoking at baseline, following treatment engagement at 8 weeks, then at 3 months and 6 months follow-up

Secondary

MeasureTime frame
Measured at baseline, following the 8-week intervention period, and at 3 and 6 months follow-up: 1. Quality of life, measured using two items from the World Health Organisation Quality of Life scale (WHOQOL-BREF) 2. Biopsychosocial functioning, measured using six items from the Recovery Progression Measure (RPM)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026